Dijon, France · Founded 2016 · Privately Held (backing)
Developer of immunotherapies designed to help harness the therapeutic potential of gut microbiota. Exeliom Biosciences is based in Dijon, France and was founded in 2016. Its last reported valuation was $7.4 million in Dec 2018. It has raised $33.3 million.
Last reported valuation
$7.4M
Oct 2026
Priced at
—
Total raised
$33.3M
Last round
—
Cap table — not yet on record
Exeliom Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Exeliom Biosciences with a free account
·The complete investor list: 19 names
·Watch Exeliom Biosciences: the Monday email on marks, rounds and moves
